ID PXDNL_HUMAN Reviewed; 1463 AA. AC A1KZ92; B5ME43; B6CGZ3; H0YBM9; Q6ZMR2; Q96LH9; DT 29-APR-2008, integrated into UniProtKB/Swiss-Prot. DT 11-JAN-2011, sequence version 3. DT 27-MAR-2024, entry version 137. DE RecName: Full=Probable oxidoreductase PXDNL {ECO:0000305}; DE EC=1.-.-.- {ECO:0000305|PubMed:24253521}; DE AltName: Full=Cardiac peroxidase; DE AltName: Full=Inactive peroxidasin-like protein {ECO:0000305|PubMed:24253521}; DE AltName: Full=Polysomal ribonuclease 1; DE Short=PRM1; DE AltName: Full=Vascular peroxidase 2; DE Flags: Precursor; GN Name=PXDNL {ECO:0000312|HGNC:HGNC:26359}; Synonyms=VPO2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-981. RX PubMed=18929642; DOI=10.1016/j.freeradbiomed.2008.09.009; RA Cheng G., Salerno J.C., Cao Z., Pagano P.J., Lambeth J.D.; RT "Identification and characterization of VPO1, a new animal heme-containing RT peroxidase."; RL Free Radic. Biol. Med. 45:1682-1694(2008). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS VAL-981; LYS-1399 AND RP GLU-1452. RC TISSUE=Heart; RA Sum A., Peterfi Z., Geiszt M.; RT "Identification of a novel peroxidase in heart."; RL Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16421571; DOI=10.1038/nature04406; RA Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., RA Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., RA Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., RA Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A., RA Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III, RA Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., RA Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P., RA Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H., RA Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B., RA O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K., RA Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L., RA Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G., RA Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W., RA Platzer M., Shimizu N., Lander E.S.; RT "DNA sequence and analysis of human chromosome 8."; RL Nature 439:331-335(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 735-1463 (ISOFORM 2), NUCLEOTIDE RP SEQUENCE [LARGE SCALE MRNA] OF 894-1463 (ISOFORM 1), AND VARIANT VAL-981. RC TISSUE=Pericardium, and Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] OF 752-1463, AND VARIANT RP VAL-981. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP FUNCTION (ISOFORM PMR1), AND SUBCELLULAR LOCATION. RX PubMed=12923263; DOI=10.1261/rna.5720303; RA Bremer K.A., Stevens A., Schoenberg D.R.; RT "An endonuclease activity similar to Xenopus PMR1 catalyzes the degradation RT of normal and nonsense-containing human beta-globin mRNA in erythroid RT cells."; RL RNA 9:1157-1167(2003). RN [7] RP ALTERNATIVE SPLICING (ISOFORM PMR1), FUNCTION, TISSUE SPECIFICITY, RP PHOSPHORYLATION, AND INTERACTION WITH SRC. RX PubMed=22543864; DOI=10.1261/rna.031369.111; RA Gu S.Q., Bakthavachalu B., Han J., Patil D.P., Otsuka Y., Guda C., RA Schoenberg D.R.; RT "Identification of the human PMR1 mRNA endonuclease as an alternatively RT processed product of the gene for peroxidasin-like protein."; RL RNA 18:1186-1196(2012). RN [8] RP FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INTERACTION WITH PXDN, RP AND INDUCTION. RX PubMed=24253521; DOI=10.1093/cvr/cvt256; RA Peterfi Z., Toth Z.E., Kovacs H.A., Lazar E., Sum A., Donko A., RA Sirokmany G., Shah A.M., Geiszt M.; RT "Peroxidasin-like protein: a novel peroxidase homologue in the human RT heart."; RL Cardiovasc. Res. 101:393-399(2014). CC -!- FUNCTION: Probable oxidoreductase (Probable). Lacks peroxidase activity CC (PubMed:24253521). Inhibits the peroxidase activity of PXDN through its CC interaction (PubMed:24253521). {ECO:0000269|PubMed:24253521, CC ECO:0000305|PubMed:24253521}. CC -!- FUNCTION: [Isoform PMR1]: Endonuclease selectively degrading some CC target mRNAs while they are engaged by translating ribosomes, among CC which albumin and beta-globin mRNAs. {ECO:0000269|PubMed:22543864}. CC -!- COFACTOR: CC Name=heme b; Xref=ChEBI:CHEBI:60344; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00298}; CC -!- SUBUNIT: Interacts with PXDN; this interaction inhibits the peroxidase CC activity of PXDN. {ECO:0000269|PubMed:24253521}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:24253521}. CC Endoplasmic reticulum {ECO:0000269|PubMed:24253521}. Cell membrane CC {ECO:0000269|PubMed:24253521}. CC -!- SUBCELLULAR LOCATION: [Isoform PMR1]: Cytoplasm. Note=Associates with CC polysomes. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=A1KZ92-1; Sequence=Displayed; CC Name=2; CC IsoId=A1KZ92-2; Sequence=VSP_033070, VSP_033071; CC Name=PMR1; CC IsoId=A1KZ92-3; Sequence=VSP_044240, VSP_044241; CC -!- TISSUE SPECIFICITY: the 57 kDa isoform PMR1 is the only form detected CC at protein levels in human cell lines (PubMed:22543864). Expressed in CC heart (PubMed:24253521). {ECO:0000269|PubMed:22543864, CC ECO:0000269|PubMed:24253521}. CC -!- INDUCTION: Increased by Angiotensin-2. {ECO:0000269|PubMed:24253521}. CC -!- PTM: Phosphorylation by SRC on tyrosine residues is required for CC targeting to polysomes. {ECO:0000269|PubMed:22543864}. CC -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily. CC {ECO:0000255|PROSITE-ProRule:PRU00298}. CC -!- SEQUENCE CAUTION: CC Sequence=AAX70929.1; Type=Frameshift; Evidence={ECO:0000305}; CC Sequence=BAB71713.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAD18663.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=EAW86707.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; EU170240; ABX24517.1; -; mRNA. DR EMBL; AY877349; AAX70929.1; ALT_FRAME; mRNA. DR EMBL; AC090186; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC103958; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC107374; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC011128; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC012413; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AK058200; BAB71713.1; ALT_INIT; mRNA. DR EMBL; AK131524; BAD18663.1; ALT_INIT; mRNA. DR EMBL; CH471068; EAW86707.1; ALT_SEQ; Genomic_DNA. DR CCDS; CCDS47855.1; -. [A1KZ92-1] DR RefSeq; NP_653252.3; NM_144651.4. [A1KZ92-1] DR AlphaFoldDB; A1KZ92; -. DR SMR; A1KZ92; -. DR BioGRID; 126492; 23. DR IntAct; A1KZ92; 4. DR STRING; 9606.ENSP00000348645; -. DR PeroxiBase; 5398; HsPxd02. DR PeroxiBase; 5827; HsPxd03. DR GlyCosmos; A1KZ92; 1 site, No reported glycans. DR GlyGen; A1KZ92; 1 site. DR iPTMnet; A1KZ92; -. DR PhosphoSitePlus; A1KZ92; -. DR BioMuta; PXDNL; -. DR EPD; A1KZ92; -. DR jPOST; A1KZ92; -. DR MassIVE; A1KZ92; -. DR MaxQB; A1KZ92; -. DR PaxDb; 9606-ENSP00000348645; -. DR PeptideAtlas; A1KZ92; -. DR ProteomicsDB; 126; -. [A1KZ92-1] DR ProteomicsDB; 127; -. [A1KZ92-2] DR ProteomicsDB; 36775; -. DR DNASU; 137902; -. DR Ensembl; ENST00000356297.5; ENSP00000348645.4; ENSG00000147485.13. [A1KZ92-1] DR GeneID; 137902; -. DR KEGG; hsa:137902; -. DR MANE-Select; ENST00000356297.5; ENSP00000348645.4; NM_144651.5; NP_653252.4. DR UCSC; uc003xqu.5; human. [A1KZ92-1] DR AGR; HGNC:26359; -. DR CTD; 137902; -. DR DisGeNET; 137902; -. DR GeneCards; PXDNL; -. DR HGNC; HGNC:26359; PXDNL. DR HPA; ENSG00000147485; Tissue enriched (heart). DR neXtProt; NX_A1KZ92; -. DR OpenTargets; ENSG00000147485; -. DR PharmGKB; PA142671110; -. DR VEuPathDB; HostDB:ENSG00000147485; -. DR eggNOG; KOG2408; Eukaryota. DR GeneTree; ENSGT00940000163562; -. DR HOGENOM; CLU_006087_0_1_1; -. DR InParanoid; A1KZ92; -. DR OMA; DCVARNS; -. DR OrthoDB; 4560at2759; -. DR PhylomeDB; A1KZ92; -. DR TreeFam; TF314316; -. DR BRENDA; 1.11.1.7; 2681. DR PathwayCommons; A1KZ92; -. DR SignaLink; A1KZ92; -. DR BioGRID-ORCS; 137902; 11 hits in 1144 CRISPR screens. DR ChiTaRS; PXDNL; human. DR GenomeRNAi; 137902; -. DR Pharos; A1KZ92; Tbio. DR PRO; PR:A1KZ92; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; A1KZ92; Protein. DR Bgee; ENSG00000147485; Expressed in cardiac muscle of right atrium and 96 other cell types or tissues. DR ExpressionAtlas; A1KZ92; baseline and differential. DR GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell. DR GO; GO:0005615; C:extracellular space; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW. DR GO; GO:0020037; F:heme binding; ISS:UniProtKB. DR GO; GO:0140825; F:lactoperoxidase activity; IEA:UniProtKB-EC. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004601; F:peroxidase activity; ISS:UniProtKB. DR GO; GO:0042744; P:hydrogen peroxide catabolic process; ISS:UniProtKB. DR GO; GO:0006979; P:response to oxidative stress; IEA:InterPro. DR CDD; cd09826; peroxidasin_like; 1. DR Gene3D; 6.20.200.20; -; 1. DR Gene3D; 1.10.640.10; Haem peroxidase domain superfamily, animal type; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 4. DR Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1. DR InterPro; IPR000483; Cys-rich_flank_reg_C. DR InterPro; IPR019791; Haem_peroxidase_animal. DR InterPro; IPR010255; Haem_peroxidase_sf. DR InterPro; IPR037120; Haem_peroxidase_sf_animal. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR013098; Ig_I-set. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR003598; Ig_sub2. DR InterPro; IPR001611; Leu-rich_rpt. DR InterPro; IPR003591; Leu-rich_rpt_typical-subtyp. DR InterPro; IPR032675; LRR_dom_sf. DR InterPro; IPR034824; Peroxidasin_peroxidase. DR InterPro; IPR001007; VWF_dom. DR PANTHER; PTHR11475; OXIDASE/PEROXIDASE; 1. DR PANTHER; PTHR11475:SF38; OXIDOREDUCTASE PXDNL-RELATED; 1. DR Pfam; PF03098; An_peroxidase; 1. DR Pfam; PF07679; I-set; 3. DR Pfam; PF13927; Ig_3; 1. DR Pfam; PF13855; LRR_8; 2. DR Pfam; PF00093; VWC; 1. DR PRINTS; PR00457; ANPEROXIDASE. DR SMART; SM00409; IG; 4. DR SMART; SM00408; IGc2; 4. DR SMART; SM00369; LRR_TYP; 6. DR SMART; SM00082; LRRCT; 1. DR SMART; SM00214; VWC; 1. DR SUPFAM; SSF57603; FnI-like domain; 1. DR SUPFAM; SSF48113; Heme-dependent peroxidases; 1. DR SUPFAM; SSF48726; Immunoglobulin; 4. DR SUPFAM; SSF52058; L domain-like; 1. DR PROSITE; PS50835; IG_LIKE; 4. DR PROSITE; PS51450; LRR; 6. DR PROSITE; PS50292; PEROXIDASE_3; 1. DR PROSITE; PS01208; VWFC_1; 1. DR PROSITE; PS50184; VWFC_2; 1. DR Genevisible; A1KZ92; HS. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Cell membrane; Cytoplasm; Disulfide bond; KW Endonuclease; Endoplasmic reticulum; Glycoprotein; Heme; Hydrolase; KW Immunoglobulin domain; Iron; Leucine-rich repeat; Membrane; Metal-binding; KW Nuclease; Oxidoreductase; Phosphoprotein; Reference proteome; Repeat; KW Secreted; Signal. FT SIGNAL 1..23 FT /evidence="ECO:0000255" FT CHAIN 24..1463 FT /note="Probable oxidoreductase PXDNL" FT /id="PRO_0000330731" FT DOMAIN 24..50 FT /note="LRRNT" FT REPEAT 51..72 FT /note="LRR 1" FT REPEAT 75..96 FT /note="LRR 2" FT REPEAT 99..120 FT /note="LRR 3" FT REPEAT 123..144 FT /note="LRR 4" FT REPEAT 147..168 FT /note="LRR 5" FT DOMAIN 180..233 FT /note="LRRCT" FT DOMAIN 234..322 FT /note="Ig-like C2-type 1" FT DOMAIN 330..414 FT /note="Ig-like C2-type 2" FT DOMAIN 419..504 FT /note="Ig-like C2-type 3" FT DOMAIN 507..596 FT /note="Ig-like C2-type 4" FT DOMAIN 1393..1451 FT /note="VWFC" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00220" FT ACT_SITE 812 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT BINDING 813 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT BINDING 891 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT BINDING 893 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT BINDING 895 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT BINDING 897 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT BINDING 1057 FT /ligand="heme b" FT /ligand_id="ChEBI:CHEBI:60344" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT SITE 960 FT /note="Transition state stabilizer" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00298" FT CARBOHYD 387 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 255..305 FT /evidence="ECO:0000250" FT DISULFID 351..398 FT /evidence="ECO:0000250" FT DISULFID 440..488 FT /evidence="ECO:0000250" FT DISULFID 532..580 FT /evidence="ECO:0000250" FT DISULFID 718..734 FT /evidence="ECO:0000250" FT DISULFID 832..842 FT /evidence="ECO:0000250" FT DISULFID 836..859 FT /evidence="ECO:0000250" FT DISULFID 944..953 FT /evidence="ECO:0000250" FT DISULFID 1160..1217 FT /evidence="ECO:0000250" FT DISULFID 1258..1284 FT /evidence="ECO:0000250" FT VAR_SEQ 1..801 FT /note="Missing (in isoform PMR1)" FT /evidence="ECO:0000305" FT /id="VSP_044240" FT VAR_SEQ 1302..1463 FT /note="CRSRGQFRAVTQESQKKRSAQYSYPVDKDMELSHLRSRQQDKIYVGEDARNV FT TVLAKTKFSQDFSTFAAEIQETITALREQINKLEARLRQAGCTDVRGVPRKAEERWMKE FT DCTHCICESGQVTCVVEICPPAPCPSPELVKGTCCPVCRDRGMPSDSPEKR -> KQAG FT GTPEAGRVYRC (in isoform PMR1)" FT /evidence="ECO:0000305" FT /id="VSP_044241" FT VAR_SEQ 1302..1316 FT /note="CRSRGQFRAVTQESQ -> KQAGGTPEAGRVYRC (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_033070" FT VAR_SEQ 1317..1463 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_033071" FT VARIANT 343 FT /note="I -> T (in dbSNP:rs7833909)" FT /id="VAR_050488" FT VARIANT 583 FT /note="R -> Q (in dbSNP:rs16916235)" FT /id="VAR_050489" FT VARIANT 616 FT /note="D -> A (in dbSNP:rs16916207)" FT /id="VAR_050490" FT VARIANT 981 FT /note="M -> V (in dbSNP:rs2977020)" FT /evidence="ECO:0000269|PubMed:14702039, FT ECO:0000269|PubMed:18929642, ECO:0000269|Ref.2, FT ECO:0000269|Ref.5" FT /id="VAR_050491" FT VARIANT 1327 FT /note="V -> D (in dbSNP:rs11774588)" FT /id="VAR_050492" FT VARIANT 1399 FT /note="R -> K (in dbSNP:rs7827446)" FT /evidence="ECO:0000269|Ref.2" FT /id="VAR_050493" FT VARIANT 1452 FT /note="D -> E (in dbSNP:rs1052704)" FT /evidence="ECO:0000269|Ref.2" FT /id="VAR_050494" FT CONFLICT 781 FT /note="R -> G (in Ref. 4; BAD18663)" FT /evidence="ECO:0000305" FT CONFLICT 833 FT /note="S -> N (in Ref. 4; BAD18663)" FT /evidence="ECO:0000305" SQ SEQUENCE 1463 AA; 163686 MW; F6FE8200892CCCAE CRC64; MEPRLFCWTT LFLLAGWCLP GLPCPSRCLC FKSTVRCMHL MLDHIPQVPQ QTTVLDLRFN RIREIPGSAF KKLKNLNTLL LNNNHIRKIS RNAFEGLENL LYLYLYKNEI HALDKQTFKG LISLEHLYIH FNQLEMLQPE TFGDLLRLER LFLHNNKLSK IPAGSFSNLD SLKRLRLDSN ALVCDCDLMW LGELLQGFAQ HGHTQAAATC EYPRRLHGRA VASVTVEEFN CQSPRITFEP QDVEVPSGNT VYFTCRAEGN PKPEIIWIHN NHSLDLEDDT RLNVFDDGTL MIRNTRESDQ GVYQCMARNS AGEAKTQSAM LRYSSLPAKP SFVIQPQDTE VLIGTSTTLE CMATGHPHPL ITWTRDNGLE LDGSRHVATS SGLYLQNITQ RDHGRFTCHA NNSHGTVQAA ANIIVQAPPQ FTVTPKDQVV LEEHAVEWLC EADGNPPPVI VWTKTGGQLP VEGQHTVLSS GTLRIDRAAQ HDQGQYECQA VSSLGVKKVS VQLTVKPKAL AVFTQLPQDT SVEVGKNINI SCHAQGEPQP IITWNKEGVQ ITESGKFHVD DEGTLTIYDA GFPDQGRYEC VARNSFGLAV TNMFLTVTAI QGRQAGDDFV ESSILDAVQR VDSAINSTRR HLFSQKPHTS SDLLAQFHYP RDPLIVEMAR AGEIFEHTLQ LIRERVKQGL TVDLEGKEFR YNDLVSPRSL SLIANLSGCT ARRPLPNCSN RCFHAKYRAH DGTCNNLQQP TWGAALTAFA RLLQPAYRDG IRAPRGLGLP VGSRQPLPPP RLVATVWARA AAVTPDHSYT RMLMHWGWFL EHDLDHTVPA LSTARFSDGR PCSSVCTNDP PCFPMNTRHA DPRGTHAPCM LFARSSPACA SGRPSATVDS VYAREQINQQ TAYIDGSNVY GSSERESQAL RDPSVPRGLL KTGFPWPPSG KPLLPFSTGP PTECARQEQE SPCFLAGDHR ANEHLALAAM HTLWFREHNR MATELSALNP HWEGNTVYQE ARKIVGAELQ HITYSHWLPK VLGDPGTRML RGYRGYNPNV NAGIINSFAT AAFRFGHTLI NPILYRLNAT LGEISEGHLP FHKALFSPSR IIKEGGIDPV LRGLFGVAAK WRAPSYLLSP ELTQRLFSAA YSAAVDSAAT IIQRGRDHGI PPYVDFRVFC NLTSVKNFED LQNEIKDSEI RQKLRKLYGS PGDIDLWPAL MVEDLIPGTR VGPTLMCLFV TQFQRLRDGD RFWYENPGVF TPAQLTQLKQ ASLSRVLCDN GDSIQQVQAD VFVKAEYPQD YLNCSEIPKV DLRVWQDCCA DCRSRGQFRA VTQESQKKRS AQYSYPVDKD MELSHLRSRQ QDKIYVGEDA RNVTVLAKTK FSQDFSTFAA EIQETITALR EQINKLEARL RQAGCTDVRG VPRKAEERWM KEDCTHCICE SGQVTCVVEI CPPAPCPSPE LVKGTCCPVC RDRGMPSDSP EKR //